Arca
Skip to content

IL1B: Interleukin-1 beta

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Potent pro-inflammatory cytokine.

  • Drugs that act on it: 5
  • With a US drug page: 2
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
CanakinumabApprovedInterleukin-1 beta inhibitorInhibitor—
RilonaceptApprovedInterleukin-1 beta inhibitorInhibitor—
CDP-484—Interleukin-1 beta inhibitorInhibitor—
Gevokizumab—Interleukin-1 beta negative allosteric modulatorNegative allosteric modulator—
Lutikizumab—Interleukin-1 beta inhibitorInhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Cryopyrin-associated periodic syndrome
0.59
Muckle-Wells syndrome
0.53
Gout
0.53
Familial Mediterranean fever
0.51
Familial cold autoinflammatory syndrome
0.47
Immune system disorder
0.47
Antisynthetase syndrome
0.46
Atopic eczema
0.46

Drugs and mechanisms are from ChEMBL CHEMBL1909490 (CC BY-SA 3.0). Gene name, function (UniProt P01584, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.